Ryousuke Satou Selected Research

Diabetes Mellitus

1/2020	Blockade of sodium-glucose cotransporter 2 suppresses high glucose-induced angiotensinogen augmentation in renal proximal tubular cells.
1/2019	Advanced Glycation End Products Stimulate Angiotensinogen Production in Renal Proximal Tubular Cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ryousuke Satou Research Topics

Disease

20	Hypertension (High Blood Pressure) 07/2022 - 05/2008
5	Body Weight (Weight, Body) 01/2016 - 07/2005
3	Diabetic Nephropathies (Diabetic Nephropathy) 01/2019 - 11/2010
3	IGA Glomerulonephritis (IGA Nephropathy) 08/2009 - 06/2007
2	Hyperglycemia 01/2020 - 01/2019
2	Diabetes Mellitus 01/2020 - 01/2019
2	Type 2 Diabetes Mellitus (MODY) 12/2019 - 01/2019
2	Kidney Diseases (Kidney Disease) 10/2014 - 05/2008
2	Glomerulonephritis 10/2014 - 03/2011
2	Nephritis 03/2011 - 05/2008
1	COVID-19 02/2024
1	Infections 02/2024
1	Renal Insufficiency (Renal Failure) 01/2024
1	Brain Death (Brain Dead) 01/2024
1	Hypotension (Low Blood Pressure) 01/2023
1	Hypovolemia 01/2023
1	Alzheimer Disease (Alzheimer's Disease) 01/2020
1	Albuminuria 12/2019
1	Neoplasms (Cancer) 08/2015
1	Inflammation (Inflammations) 05/2012
1	Fibrosis (Cirrhosis) 04/2011
1	Porcine Reproductive and Respiratory Syndrome (PRRS) 04/2011
1	Proteinuria 03/2011
1	Chronic Renal Insufficiency 09/2008

Drug/Important Bio-Agent (IBA)

17	AngiotensinogenIBA 07/2022 - 06/2007
10	Angiotensin IIIBA 07/2022 - 07/2005
7	ReninIBA 01/2023 - 09/2008
5	SodiumIBA 01/2020 - 09/2008
4	CytokinesIBA 07/2022 - 05/2012
3	Proteins (Proteins, Gene)FDA Link 01/2019 - 01/2010
3	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 03/2011 - 02/2009
3	Immunoglobulin A (IgA)IBA 08/2009 - 05/2008
2	PotassiumIBA 01/2023 - 09/2008
2	SaltsIBA 01/2020 - 07/2012
2	Messenger RNA (mRNA)IBA 01/2019 - 10/2014
2	AngiotensinsIBA 01/2017 - 02/2009
2	Interleukin-6 (Interleukin 6)IBA 01/2016 - 05/2012
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2012 - 10/2010
2	Reactive Oxygen Species (Oxygen Radicals)IBA 08/2009 - 05/2009
2	CreatinineIBA 02/2009 - 09/2008
2	Angiotensin IIIIBA 12/2005 - 07/2005
1	AntibodiesIBA 02/2024
1	Antiviral Agents (Antivirals)IBA 02/2024
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 07/2022
1	Chymases (Chymase)IBA 12/2019
1	RNA (Ribonucleic Acid)IBA 01/2019
1	8-epi-prostaglandin F2alphaIBA 01/2019
1	Advanced Glycation End ProductsIBA 01/2019
1	CanagliflozinIBA 01/2019
1	Type 1 Angiotensin ReceptorIBA 01/2016
1	Plasminogen Activators (Plasminogen Activator)IBA 10/2014
1	Transforming Growth Factors (Transforming Growth Factor)IBA 10/2014
1	aliskiren FDA Link 10/2014
1	rho-Associated KinasesIBA 03/2014
1	InterferonsIBA 05/2012
1	Angiotensin IIBA 03/2011
1	antiglomerular basement membrane antibodyIBA 03/2011
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 03/2011
1	Angiotensin II Type 1 Receptor BlockersIBA 03/2011
1	CCR2 ReceptorsIBA 03/2011
1	Phosphotransferases (Kinase)IBA 11/2010
1	Biomarkers (Surrogate Marker)IBA 09/2008

Therapy/Procedure

2	Kidney Transplantation 01/2024 - 01/2023
1	Heterologous Transplantation (Xenotransplantation) 01/2024
1	Nephrectomy 01/2024
1	Therapeutics 03/2011